Skip to main content

Emmaus Life Sciences, Inc.

EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000822370

In the last 90 days, Emmaus Life Sciences, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Emmaus Life Sciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $18.1K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$18.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Emmaus Life Sciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Emmaus Life Sciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Lee Willis CCEO690,167IndirectSep 2, 20261
Lim Seah H.Director4,606,626Sep 18, 20240
Zwicker Ian HarveyDirector–Feb 5, 20240
ZEN Wei PeuDirector4,768,817Feb 5, 20240
Stark Charles WilliamCSO & EVP Clinical Development–Feb 5, 20240
Sekulich GeorgeCo-President & CCO–Feb 5, 20240
Nagasaki YasushiCFO–Feb 5, 20240
Niihara YutakaChairman and CEO12,040,857Jan 17, 20230
Lui Alfred Fu KongDirector10,000Jan 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 23, 2021 (view filing)Nov 19-224 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+27.0K$1.41+$38.1K+0.2%10.9M after2 lots
Nov 19, 2021 (view filing)Nov 15-184 daysLateNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+33.0K$1.28+$42.3K+0.3%10.9M after4 lots
Oct 22, 2021 (view filing)Oct 202 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+1.00K$1.57+$1.57K0.0%10.9M after
Oct 7, 2021 (view filing)Oct 5-62 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+3.00K$1.61+$4.84K0.0%10.9M after2 lots
Sep 29, 2021 (view filing)Sep 272 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+1.00K$1.64+$1.64K0.0%10.9M after
Sep 27, 2021 (view filing)Sep 23-244 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+2.50K$1.69+$4.24K0.0%10.9M after2 lots
Sep 23, 2021 (view filing)Sep 21-222 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+3.58K$1.68+$6.02K0.0%10.9M after2 lots
Sep 17, 2021 (view filing)Sep 15-172 daysLee Willis CVice Chairman & COOPPurchaseCommon stock, $0.001 par value+3.50K$1.60+$5.58K+3.1%116.3K after3 lots
Sep 17, 2021 (view filing)Sep 152 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+2.00K$1.50+$3.00K0.0%10.9M after
Sep 13, 2021 (view filing)Sep 94 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+2.50K$1.67+$4.17K0.0%10.9M after
Sep 10, 2021 (view filing)Sep 8-102 daysLee Willis CVice Chairman & COOPPurchaseCommon stock, $0.001 par value+4.00K$1.71+$6.84K+3.7%112.8K after2 lots
Sep 8, 2021 (view filing)Sep 3-85 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+3.00K$1.67+$5.00K0.0%10.9M after2 lots
Sep 2, 2021 (view filing)Aug 31-Sep 22 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+9.70K$1.55+$15.0K+0.1%10.9M after3 lots
Aug 27, 2021 (view filing)Aug 25-272 daysLee Willis CVice Chairman & COOPPurchaseCommon stock, $0.001 par value+4.90K$1.56+$7.62K+2.0%255.6K after3 lots
Aug 26, 2021 (view filing)Aug 24-262 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+13.2K$1.54+$20.3K+0.1%10.9M after3 lots
Aug 23, 2021 (view filing)Aug 19-234 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+9.20K$1.45+$13.3K+0.1%10.8M after3 lots
Aug 18, 2021 (view filing)Aug 16-182 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+4.70K$1.50+$7.04K0.0%10.8M after3 lots
Aug 13, 2021 (view filing)Aug 11-132 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+7.59K$1.53+$11.6K+0.1%10.8M after3 lots
Aug 10, 2021 (view filing)Aug 6-94 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+5.10K$1.52+$7.77K0.0%10.8M after2 lots
Aug 5, 2021 (view filing)Aug 3-52 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+7.60K$1.48+$11.2K+0.1%10.8M after3 lots
Aug 2, 2021 (view filing)Jul 29-Aug 24 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+4.10K$1.48+$6.07K0.0%10.8M after3 lots
Jul 28, 2021 (view filing)Jul 26-282 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+3.40K$1.47+$5.00K0.0%10.8M after3 lots
Jul 23, 2021 (view filing)Jul 21-232 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+5.20K$1.47+$7.66K0.0%10.8M after3 lots
Jul 20, 2021 (view filing)Jul 16-204 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+4.90K$1.47+$7.21K0.0%10.8M after3 lots
Jul 15, 2021 (view filing)Jul 13-152 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+5.30K$1.51+$7.99K0.0%10.8M after3 lots
Jul 12, 2021 (view filing)Jul 8-124 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+4.00K$1.54+$6.15K0.0%10.8M after3 lots
Jul 7, 2021 (view filing)Jul 2-75 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+3.90K$1.53+$5.96K0.0%10.8M after3 lots
Jul 1, 2021 (view filing)Jun 29-Jul 12 daysNiihara YutakaChairman and CEOPPurchaseCommon stock, $0.001 par value+10.0K$1.45+$14.5K+0.1%10.8M after3 lots